With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
This pattern of practice analysis reveals that the use of radiation for ALK+ non-small cell lung cancer brain mets has decreased after 2017 with newer ALK-targeted therapies coming on the scene. | Kumar, Int J Radiat Oncol Biol Phys 2022